Influence of ageing on the design, manufacture and use of drug delivery systems
Wednesday, July 28 12pm - 4pm EDT & 5pm-9pm EDT
|
Sponsored By:
|
|
|
|
More older people are accessing medical care than ever before. As the global population ages, healthcare providers and the pharmaceutical industry should ensure that services are appropriate to meet the changing needs of their patients. We know that older people often have distinct requirements when it comes to their medicines. This workshop will focus on the pharmaceutical needs of older patients and outline emerging innovation across the spectrum of tailored drug delivery systems for older patients.
The talks in this workshop will focus on: (i) Oral biopharmaceutics of medicines for older patients, (ii) Medicines self-management by older people, (iii) The ageing microbiome and its effects on medicine performance, (iv) The ageing gut: oral drug and food absorption, (v) PKPD models to describe drug action in older patients, (vi) Novel drug delivery systems for the treatment and care of older patients, (vii) Industry perspective about the manufacture of patient centric dosage forms, (viii) Methodologies to assess the medicine acceptability for older people, (ix) 3D printed formulations, machine learning, and how we can utilize additive manufacturing and digital pharmaceutics for better medicines for older patients.
The session will be of interest to academics, pharmaceutical industry formulation scientists, healthcare engineers, and clinicians. Upon completion of this workshop, attendees will have a good understanding of the ageing population’s pharmaceutical requirements, and the emerging research that promises to enhance older people’s experience of taking medicines.
The talks in this workshop will focus on: (i) Oral biopharmaceutics of medicines for older patients, (ii) Medicines self-management by older people, (iii) The ageing microbiome and its effects on medicine performance, (iv) The ageing gut: oral drug and food absorption, (v) PKPD models to describe drug action in older patients, (vi) Novel drug delivery systems for the treatment and care of older patients, (vii) Industry perspective about the manufacture of patient centric dosage forms, (viii) Methodologies to assess the medicine acceptability for older people, (ix) 3D printed formulations, machine learning, and how we can utilize additive manufacturing and digital pharmaceutics for better medicines for older patients.
The session will be of interest to academics, pharmaceutical industry formulation scientists, healthcare engineers, and clinicians. Upon completion of this workshop, attendees will have a good understanding of the ageing population’s pharmaceutical requirements, and the emerging research that promises to enhance older people’s experience of taking medicines.
